Search
for
Sort by
Research 61–90 of 1000+
- Nilotinib-induced generalized keratosis pilaris: Report of a rare case
- Sorafenib-induced Facial Acneiform Eruption
- Concomitant occurrence of acneiform eruption, alopecia areata, and urticaria during adalimumab treatment in a patient with pustulosis palmoplantaris: Case report and literature review
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Ocular Events Temporally Associated With Minoxidil: A Structured Review
- Spontaneous cutaneous adverse drug reaction reports—An analysis of a 10‐year dataset in Singapore
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Dermatologic Adverse Events from Cancer Treatments
- Adverse events associated with vismodegib: insights from a real-world pharmacovigilance study using the FAERS database
- Differences in reproductive toxicology between alopecia drugs: an analysis on adverse events among female and male cases
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- Target-Adverse Events and Fear of Cancer Progression, Anxiety, and Depression in Patients with Advanced Non-Small Cell Lung Cancer
- Adverse Cutaneous Reactions to Antipsychotics
- Adverse Cutaneous Reactions to Antidepressants
- Safety profile of ipilimumab in elderly patients: a disproportionate analysis based on the FDA Adverse Event Reporting System database
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Severe cutaneous adverse reactions to drugs
- Adverse Cutaneous Reactions to Mood Stabilizers
- Adverse cutaneous effects of psychotropic medications
- Adverse events of non-ablative fractional laser photothermolysis: a retrospective study of 856 treatments in 362 patients
- Reporting on Adverse Clinical Events
- Reporting on Adverse Clinical Events
- Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
- Investigating tralokinumab-related adverse events in treating atopic dermatitis: insights from the FAERS database
- Hair and nail adverse events during treatment with target therapies for metastatic melanoma
- Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor
- Suicidal behaviors (suicidal ideation, suicide attempt and completed suicide) in patients treated with finasteride for hair loss: Results from the U.S. FDA Adverse Event Reporting System (FAERS) database
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
- Cutaneous Adverse Effects of EGFR Therapy in Breast Cancer Treatment
- Cutaneous adverse effects of chemotherapy in cancer patients: A clinico epidemiological study